| Drugname |
Patent Number |
Patent Title |
Patent Assignee |
Estimated Expiration |
| DDP-225 |
➤ Sign Up |
Use of 4-(2-Flurophenyl)-6-methyl-2-(1-piperazinyl)thieno(2,3-D)-pyrimidin- e for treating of urinary incontinence |
Arachnova Therapeutics Ltd. (Jersey, GB) |
➤ Sign Up |
| DDP-225 |
➤ Sign Up |
4-(2-Fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D)pyrimidine in the treatment of functional bowel disorder |
Dynogen Pharmaceuticals, Inc. (Waltham, MA) |
➤ Sign Up |
| DDP-225 |
➤ Sign Up |
Substituted phenoxy thiazolidinediones as estrogen related receptor-.alpha. modulators |
Janssen Pharmaceutica, NV (Beerse, BE) |
➤ Sign Up |
| DDP-225 |
➤ Sign Up |
Substituted phenoxy N-alkylated thiazolidinediones as estrogen related receptor-.alpha. modulators |
Janssen Pharmaceutica N.V. (Beerse, BE) |
➤ Sign Up |
| Drugname |
Patent Number |
Patent Title |
Patent Assignee |
Estimated Expiration |
This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
